company background image
HIQ

HITIQASX:HIQ Stock Report

Market Cap

AU$25.8m

7D

8.8%

1Y

n/a

Updated

26 Oct, 2021

Data

Company Financials
HIQ fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

HIQ Overview

HitIQ Limited develops and commercializes concussion management technology in Australia.

Price History & Performance

Summary of all time highs, changes and price drops for HITIQ
Historical stock prices
Current Share PriceAU$0.18
52 Week HighAU$0.12
52 Week LowAU$0.30
Beta0
1 Month Change19.36%
3 Month Change12.12%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-19.56%

Recent News & Updates

Shareholder Returns

HIQAU Healthcare ServicesAU Market
7D8.8%3.3%0.8%
1Yn/a46.5%24.4%

Return vs Industry: Insufficient data to determine how HIQ performed against the Australian Healthcare Services industry.

Return vs Market: Insufficient data to determine how HIQ performed against the Australian Market.

Price Volatility

Is HIQ's price volatile compared to industry and market?
HIQ volatility
HIQ Beta0
Industry Beta0.48
Market Beta1

Stable Share Price: HIQ is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: Insufficient data to determine HIQ's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
201525Mike Vegarhttps://hitiq.com

HitIQ Limited develops and commercializes concussion management technology in Australia. The company offers Nexus A9 sensor to record individual head impacts. Its Nexus software delivers a platform for measuring and managing head impact exposures, as well as allows users to quantify exposures across individual players, positions, periods, and drills.

HITIQ Fundamentals Summary

How do HITIQ's earnings and revenue compare to its market cap?
HIQ fundamental statistics
Market CapAU$25.82m
Earnings (TTM)-AU$5.06m
Revenue (TTM)AU$406.68k

60.3x

P/S Ratio

-4.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HIQ income statement (TTM)
RevenueAU$406.68k
Cost of RevenueAU$3.34m
Gross Profit-AU$2.93m
ExpensesAU$2.13m
Earnings-AU$5.06m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.038
Gross Margin-720.12%
Net Profit Margin-1,244.92%
Debt/Equity Ratio7.4%

How did HIQ perform over the long term?

See historical performance and comparison

Valuation

Is HITIQ undervalued compared to its fair value and its price relative to the market?

3.09x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate HIQ's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate HIQ's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: HIQ is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.

PE vs Market: HIQ is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate HIQ's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: HIQ is good value based on its PB Ratio (3.1x) compared to the AU Healthcare Services industry average (4.1x).


Future Growth

How is HITIQ forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

40.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HITIQ has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has HITIQ performed over the past 5 years?

-93.3%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: HIQ is currently unprofitable.

Growing Profit Margin: HIQ is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if HIQ's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare HIQ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HIQ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (37.7%).


Return on Equity

High ROE: HIQ has a negative Return on Equity (-63.9%), as it is currently unprofitable.


Financial Health

How is HITIQ's financial position?


Financial Position Analysis

Short Term Liabilities: HIQ's short term assets (A$9.2M) exceed its short term liabilities (A$1.6M).

Long Term Liabilities: HIQ has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: HIQ's debt to equity ratio (7.4%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if HIQ's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HIQ has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: HIQ has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 19.4% each year


Dividend

What is HITIQ current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate HIQ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HIQ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HIQ's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HIQ's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HIQ's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

AU$764k

CEO Compensation


CEO

Mike Vegar

no data

Tenure

AU$764,044

Compensation

Mr. Michael Dean Vegar, also known as Mike, serves as Managing Director, Chief Executive Officer and Director at HITIQ LIMITED. Mr. Vegar is a co-founder of HitIQ. He has been responsible for creating and...


CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD572.75K) is above average for companies of similar size in the Australian market ($USD301.38K).

Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: HIQ insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: HIQ only recently listed within the past 12 months.


Top Shareholders

Company Information

HITIQ Limited's employee growth, exchange listings and data sources


Key Information

  • Name: HITIQ Limited
  • Ticker: HIQ
  • Exchange: ASX
  • Founded: 2015
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$25.822m
  • Shares outstanding: 132.42m
  • Website: https://hitiq.com

Number of Employees


Location

  • HITIQ Limited
  • 9-17 Raglan Street
  • Suite 1
  • Melbourne
  • Victoria
  • 3205
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 07:01
End of Day Share Price2021/10/26 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.